Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Releases
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Email Alerts
    • Contact IR

Press Releases

Press Releases

Recent Releases

May 16, 2022
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest

May 16, 2022
Athira Pharma Presents Preclinical Data at the 2022 Peripheral Nerve Society (PNS) Annual Meeting

May 12, 2022
Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates

Press Releases
July 1, 2019
Athira Pharma's Leen Kawas Selected as Young Leader by French-American Foundation
May 1, 2019
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
April 11, 2019
M3 Biotechnology Announces Name Change to Athira Pharma, Inc.

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Current page 8
Displaying 71 - 73 of 73
< SIGN UP FOR EMAIL ALERTS
CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

FCOI Policy

Privacy Policy

© Athira Pharma, Inc. All rights reserved.